Tidepath

Peptide library

Repair and recovery peptides

Mostly animal and lab research. Very little in people.

The case for how these four might work comes mostly from animal and cell studies, with very little research in people. That isn't a reason to dismiss them. It does mean the doses people report aren't settled.

Tidepath has no checked dose range for any of them: the ranges it held came from sources it never named or kept on file, so they were removed. We found no controlled study in people that worked out a dose of any of them to inject, and nothing in our sources shows that any injected amount is safe or that it works.

In this group

The identity problem

Two peptides here can be mistaken for a close relative that is a different molecule, and mixing them up can make the evidence look stronger than it is. TB-500 is a small piece of thymosin beta-4, not the whole protein, so studies of the whole protein in people can't be assumed to apply to TB-500. GHK-Cu is GHK bound to copper. It's related to plain GHK but not the same thing. Tidepath asks which one you mean instead of guessing, because a quiet guess is how one molecule ends up borrowing another's evidence.

What we don't cover

Apart from the FDA's safety notes on BPC-157, TB-500, injected GHK-Cu and KPV, which are on their pages, these pages don't cover side effects, who shouldn't take them (contraindications), or drug interactions. They also make no claims that these peptides work.

Get an early invite to Tidepath

The app isn't in the App Store yet. Leave your email for an early invite, and tips for your first month.

Get an early invite, tips and occasional news from Tidepath. Unsubscribe anytime. Privacy · Health data privacy · Sender and contact details